Vipendra Kumar Singh

616 total citations
26 papers, 443 citations indexed

About

Vipendra Kumar Singh is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vipendra Kumar Singh has authored 26 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vipendra Kumar Singh's work include Computational Drug Discovery Methods (3 papers), Prostate Cancer Treatment and Research (3 papers) and MicroRNA in disease regulation (2 papers). Vipendra Kumar Singh is often cited by papers focused on Computational Drug Discovery Methods (3 papers), Prostate Cancer Treatment and Research (3 papers) and MicroRNA in disease regulation (2 papers). Vipendra Kumar Singh collaborates with scholars based in India, United States and Australia. Vipendra Kumar Singh's co-authors include Manoj Kumar Barthwal, Rajiv Lochan Tiwari, Deepika Arora, Mohd Adnan Kausar, Mοhd Saeed, Irfan Ahmad Ansari, Fahad Khan, Pradeep Kumar Sharma, Biju Bhargavan and Dhirendra P. Singh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Environmental Pollution.

In The Last Decade

Vipendra Kumar Singh

23 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vipendra Kumar Singh India 10 181 84 65 64 51 26 443
Yuting Yang China 9 182 1.0× 41 0.5× 65 1.0× 65 1.0× 30 0.6× 17 446
Linbo Zhang China 12 186 1.0× 76 0.9× 58 0.9× 69 1.1× 54 1.1× 20 442
Ankur Karmokar United Kingdom 9 306 1.7× 57 0.7× 137 2.1× 76 1.2× 40 0.8× 15 640
Jung Yoon Jang South Korea 15 263 1.5× 43 0.5× 86 1.3× 64 1.0× 87 1.7× 22 571
Jin-Jin Lin Taiwan 7 288 1.6× 63 0.8× 93 1.4× 51 0.8× 39 0.8× 9 552
Ahmed E. Goda Egypt 13 325 1.8× 61 0.7× 131 2.0× 90 1.4× 37 0.7× 22 604
Meng‐Liang Lin Taiwan 13 319 1.8× 76 0.9× 83 1.3× 98 1.5× 35 0.7× 27 619
Nurul Husna Shafie Malaysia 12 234 1.3× 33 0.4× 68 1.0× 47 0.7× 34 0.7× 34 527
Bendangla Changkija India 9 233 1.3× 81 1.0× 138 2.1× 40 0.6× 31 0.6× 14 511

Countries citing papers authored by Vipendra Kumar Singh

Since Specialization
Citations

This map shows the geographic impact of Vipendra Kumar Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vipendra Kumar Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vipendra Kumar Singh more than expected).

Fields of papers citing papers by Vipendra Kumar Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vipendra Kumar Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vipendra Kumar Singh. The network helps show where Vipendra Kumar Singh may publish in the future.

Co-authorship network of co-authors of Vipendra Kumar Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Vipendra Kumar Singh. A scholar is included among the top collaborators of Vipendra Kumar Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vipendra Kumar Singh. Vipendra Kumar Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Prateek, et al.. (2025). Signal Peptide of Human Serum Albumin (residues 1–18) Forms Amyloid-like Aggregates. ACS Omega. 10(30). 32673–32679. 1 indexed citations
2.
Jassal, Amanpreet Kaur, Vipendra Kumar Singh, Neha Garg, et al.. (2025). Exploring the recognition behavior of a fluorescein-based probe towards the significant detection of Cu2+ and Zn2+ ions: Experimental and computational studies. Journal of Photochemistry and Photobiology A Chemistry. 462. 116268–116268. 1 indexed citations
3.
5.
Singh, Vipendra Kumar, et al.. (2024). Role of MicroRNA-21 in Prostate Cancer Progression and Metastasis: Molecular Mechanisms to Therapeutic Targets. Annals of Surgical Oncology. 31(7). 4795–4808. 6 indexed citations
6.
Singh, Vipendra Kumar, et al.. (2024). Exploring the role of pomalidomide in androgen-dependent prostate cancer: a computational analysis. Molecular Diversity. 29(6). 5561–5575. 4 indexed citations
7.
Singh, Vipendra Kumar, et al.. (2023). Immunomodulatory potential of bioactive glycoside syringin: a network pharmacology and molecular modeling approach. Journal of Biomolecular Structure and Dynamics. 42(8). 3906–3919. 9 indexed citations
8.
Singh, Vipendra Kumar, et al.. (2023). The multi-protein targeting potential of bioactive syringin in inflammatory diseases: using molecular modelling and in-silico analysis of regulatory elements. Journal of Biomolecular Structure and Dynamics. 42(23). 12851–12862. 6 indexed citations
9.
Singh, Vipendra Kumar, et al.. (2023). Animal sourced biopolymer for mitigating xenobiotics and hazardous materials. Physical Sciences Reviews. 9(4). 1731–1746. 2 indexed citations
10.
Singh, Vipendra Kumar, et al.. (2023). Chloroquine synergizes doxorubicin efficacy in cervical cancer cells through flux impairment and down regulation of proteins involved in the fusion of autophagosomes to lysosomes. Biochemical and Biophysical Research Communications. 656. 131–138. 9 indexed citations
11.
Singh, Vipendra Kumar, et al.. (2023). Recent advancements in coordination compounds and their potential clinical application in the management of diseases: An up-to-date review. Polyhedron. 241. 116485–116485. 28 indexed citations
13.
Singh, Vipendra Kumar, et al.. (2022). Serum deprivation enhanced ethanol-induced toxic responses in A549, lung carcinoma cells. Journal of Environmental Biology. 43(1). 26–34.
14.
Singh, Vipendra Kumar, et al.. (2022). Crosstalk between epigenetics and tumor promoting androgen signaling in prostate cancer. Vitamins and hormones. 253–282. 3 indexed citations
15.
16.
Khan, Fahad, Vipendra Kumar Singh, Mοhd Saeed, Mohd Adnan Kausar, & Irfan Ahmad Ansari. (2019). Carvacrol Induced Program Cell Death and Cell Cycle Arrest in Androgen-Independent Human Prostate Cancer Cells via Inhibition of Notch Signaling. Anti-Cancer Agents in Medicinal Chemistry. 19(13). 1588–1608. 53 indexed citations
17.
Singh, Vipendra Kumar, et al.. (2017). Intricatinol synergistically enhances the anticancerous activity of cisplatin in human A549 cells via p38 MAPK/p53 signalling. APOPTOSIS. 22(10). 1273–1286. 22 indexed citations
18.
Singh, Vipendra Kumar. (2017). Effect of application of honey in chemoradiation-induced mucositis and to assess its clinical benefits in improving quality of life in patients of head and neck cancer. International Journal of Oral and Maxillofacial Surgery. 46. 248–249. 3 indexed citations
20.
Tiwari, Rajiv Lochan, Vipendra Kumar Singh, & Manoj Kumar Barthwal. (2007). Macrophages: An elusive yet emerging therapeutic target of atherosclerosis. Medicinal Research Reviews. 28(4). 483–544. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026